Anesthesiology Doctors in Hallandale Beach, FL Accepting Medicare

1 Anesthesiology doctors found. Showing 1 - 1

Theodore S Katsnelson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1865 S Ocean Dr, 14a, Hallandale Beach, FL 33009 Phone: 513-293-6061

News Archive

Eat 'heart-healthy' oats to prevent atherosclerosis

Nutritionist Mohsen Meydani, director of the Vascular Biology Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in Boston, Mass., led the research on the oat compounds, called avenanthramides. Meydani previously has shown that phenolic antioxidants in oats obstruct the ability of blood cells to stick to artery walls.

Study finds gender bias among emergency medicine residents during training programs

Although female doctors training to become emergency medicine specialists scored as well as their male colleagues during the first year of their three-year programs, by the end of the third year, male residents, on average, received higher evaluations on all 23 emergency medicine training categories - including medical knowledge, patient safety, team management and communication - than female residents.

Does secondhand smoke increase the risk of cardiovascular disease in children?

Whether exposure to secondhand smoke increases the chance that children with a family history of cardiovascular disease will develop the disease themselves is under study at the Medical College of Georgia.

Webinar features recent updates on meaningful use of certified EHR systems

Community oncologists, practice administrators and clinical staff interested in learning how the American Recovery and Reinvestment Act (ARRA), otherwise known as the stimulus package, can affect health care IT plans for community-based oncology practices are invited to attend a free webinar at 2 p.m. EST (11 a.m. PST) on Friday, Jan. 15, 2010. To register, visit www.MyOncologyServices.com/HIT. Registration is free, but space is limited.

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.

Read more Medical News

› Verified 7 days ago